The Jimmy and Rosalynn Carter Humanitarian Award honors individuals whose outstanding humanitarian efforts and achievements have contributed significantly to improving global public health.
Anne E. Goldfeld, MD, of Harvard Medical School and Boston Children’s Hospital, will receive the 2025 NFID Jimmy and Rosalynn Carter Humanitarian Award in recognition of her groundbreaking contributions as a physician-scientist and humanitarian who has focused on changing the course of 2 of the deadliest epidemics of our time: tuberculosis (TB) and HIV/AIDS. A visionary leader at the intersection of science and service, her work has provided a new understanding behind the immune response to TB/HIV co-infection. Beyond the lab, Goldfeld co-founded transformative treatment and research programs in Cambodia and Ethiopia for TB, drug-resistant TB, and HIV—bringing care to some of the world’s most underserved populations. Earlier in her career, she led humanitarian responses in conflict zones and was an advocate and one of the first voices calling for a global ban of landmines. Her leadership helped change global guidelines for HIV/TB treatment, now estimated to save more than 150,000 lives annually. “Anne Goldfeld is a brilliant and creative physician-scientist, visionary, and a true humanitarian,” said Gail H. Cassell, PhD, senior lecturer, Department of Global Health and Social Medicine at Harvard Medical School. “I have never met anyone in global public health who has made a more profound impact.”
Tribute Video
Acceptance Speech
For additional perspectives from Anne E. Goldfeld, MD, listen to the NFID Infectious IDeas podcast episode, Hope, Healing, and Human Rights:
